GO:0008380 | RNA splicing | 5.21e-04 | 1.00e+00 | 4.150 | 3 | 21 | 165 |
GO:0004832 | valine-tRNA ligase activity | 1.02e-03 | 1.00e+00 | 9.931 | 1 | 1 | 1 |
GO:0061383 | trabecula morphogenesis | 1.02e-03 | 1.00e+00 | 9.931 | 1 | 1 | 1 |
GO:0002128 | tRNA nucleoside ribose methylation | 1.02e-03 | 1.00e+00 | 9.931 | 1 | 1 | 1 |
GO:0008175 | tRNA methyltransferase activity | 1.02e-03 | 1.00e+00 | 9.931 | 1 | 1 | 1 |
GO:0006438 | valyl-tRNA aminoacylation | 1.02e-03 | 1.00e+00 | 9.931 | 1 | 1 | 1 |
GO:0010467 | gene expression | 1.44e-03 | 1.00e+00 | 2.868 | 4 | 49 | 535 |
GO:0033688 | regulation of osteoblast proliferation | 2.05e-03 | 1.00e+00 | 8.931 | 1 | 1 | 2 |
GO:1902177 | positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway | 3.07e-03 | 1.00e+00 | 8.347 | 1 | 1 | 3 |
GO:0046914 | transition metal ion binding | 3.07e-03 | 1.00e+00 | 8.347 | 1 | 1 | 3 |
GO:0034773 | histone H4-K20 trimethylation | 4.09e-03 | 1.00e+00 | 7.931 | 1 | 1 | 4 |
GO:0036089 | cleavage furrow formation | 4.09e-03 | 1.00e+00 | 7.931 | 1 | 1 | 4 |
GO:0036124 | histone H3-K9 trimethylation | 4.09e-03 | 1.00e+00 | 7.931 | 1 | 2 | 4 |
GO:0007176 | regulation of epidermal growth factor-activated receptor activity | 4.09e-03 | 1.00e+00 | 7.931 | 1 | 1 | 4 |
GO:0070934 | CRD-mediated mRNA stabilization | 5.11e-03 | 1.00e+00 | 7.610 | 1 | 2 | 5 |
GO:0038027 | apolipoprotein A-I-mediated signaling pathway | 5.11e-03 | 1.00e+00 | 7.610 | 1 | 1 | 5 |
GO:0043931 | ossification involved in bone maturation | 5.11e-03 | 1.00e+00 | 7.610 | 1 | 1 | 5 |
GO:0002161 | aminoacyl-tRNA editing activity | 5.11e-03 | 1.00e+00 | 7.610 | 1 | 1 | 5 |
GO:0042382 | paraspeckles | 5.11e-03 | 1.00e+00 | 7.610 | 1 | 3 | 5 |
GO:0002181 | cytoplasmic translation | 6.13e-03 | 1.00e+00 | 7.347 | 1 | 1 | 6 |
GO:0001055 | RNA polymerase II activity | 6.13e-03 | 1.00e+00 | 7.347 | 1 | 3 | 6 |
GO:0042754 | negative regulation of circadian rhythm | 6.13e-03 | 1.00e+00 | 7.347 | 1 | 2 | 6 |
GO:0043297 | apical junction assembly | 6.13e-03 | 1.00e+00 | 7.347 | 1 | 1 | 6 |
GO:0070937 | CRD-mediated mRNA stability complex | 6.13e-03 | 1.00e+00 | 7.347 | 1 | 2 | 6 |
GO:0007617 | mating behavior | 7.15e-03 | 1.00e+00 | 7.124 | 1 | 1 | 7 |
GO:0000380 | alternative mRNA splicing, via spliceosome | 7.15e-03 | 1.00e+00 | 7.124 | 1 | 2 | 7 |
GO:0000398 | mRNA splicing, via spliceosome | 7.16e-03 | 1.00e+00 | 3.931 | 2 | 15 | 128 |
GO:0006878 | cellular copper ion homeostasis | 8.17e-03 | 1.00e+00 | 6.931 | 1 | 1 | 8 |
GO:0090307 | spindle assembly involved in mitosis | 8.17e-03 | 1.00e+00 | 6.931 | 1 | 2 | 8 |
GO:0006450 | regulation of translational fidelity | 8.17e-03 | 1.00e+00 | 6.931 | 1 | 1 | 8 |
GO:0043296 | apical junction complex | 8.17e-03 | 1.00e+00 | 6.931 | 1 | 1 | 8 |
GO:0005654 | nucleoplasm | 8.69e-03 | 1.00e+00 | 2.157 | 4 | 68 | 876 |
GO:0001967 | suckling behavior | 1.02e-02 | 1.00e+00 | 6.610 | 1 | 4 | 10 |
GO:0005736 | DNA-directed RNA polymerase I complex | 1.02e-02 | 1.00e+00 | 6.610 | 1 | 4 | 10 |
GO:0030518 | intracellular steroid hormone receptor signaling pathway | 1.02e-02 | 1.00e+00 | 6.610 | 1 | 2 | 10 |
GO:0050919 | negative chemotaxis | 1.02e-02 | 1.00e+00 | 6.610 | 1 | 1 | 10 |
GO:0001054 | RNA polymerase I activity | 1.02e-02 | 1.00e+00 | 6.610 | 1 | 4 | 10 |
GO:0006367 | transcription initiation from RNA polymerase II promoter | 1.11e-02 | 1.00e+00 | 3.601 | 2 | 18 | 161 |
GO:0042809 | vitamin D receptor binding | 1.12e-02 | 1.00e+00 | 6.472 | 1 | 2 | 11 |
GO:0003677 | DNA binding | 1.14e-02 | 1.00e+00 | 2.044 | 4 | 52 | 947 |
GO:0006349 | regulation of gene expression by genetic imprinting | 1.22e-02 | 1.00e+00 | 6.347 | 1 | 1 | 12 |
GO:0050772 | positive regulation of axonogenesis | 1.32e-02 | 1.00e+00 | 6.231 | 1 | 2 | 13 |
GO:0050770 | regulation of axonogenesis | 1.32e-02 | 1.00e+00 | 6.231 | 1 | 3 | 13 |
GO:0005666 | DNA-directed RNA polymerase III complex | 1.32e-02 | 1.00e+00 | 6.231 | 1 | 3 | 13 |
GO:0005665 | DNA-directed RNA polymerase II, core complex | 1.32e-02 | 1.00e+00 | 6.231 | 1 | 3 | 13 |
GO:0001056 | RNA polymerase III activity | 1.32e-02 | 1.00e+00 | 6.231 | 1 | 3 | 13 |
GO:0042346 | positive regulation of NF-kappaB import into nucleus | 1.32e-02 | 1.00e+00 | 6.231 | 1 | 1 | 13 |
GO:0006386 | termination of RNA polymerase III transcription | 1.43e-02 | 1.00e+00 | 6.124 | 1 | 3 | 14 |
GO:0006385 | transcription elongation from RNA polymerase III promoter | 1.43e-02 | 1.00e+00 | 6.124 | 1 | 3 | 14 |
GO:0050771 | negative regulation of axonogenesis | 1.43e-02 | 1.00e+00 | 6.124 | 1 | 2 | 14 |
GO:0043393 | regulation of protein binding | 1.43e-02 | 1.00e+00 | 6.124 | 1 | 2 | 14 |
GO:0070932 | histone H3 deacetylation | 1.53e-02 | 1.00e+00 | 6.025 | 1 | 2 | 15 |
GO:0032467 | positive regulation of cytokinesis | 1.63e-02 | 1.00e+00 | 5.931 | 1 | 1 | 16 |
GO:0017022 | myosin binding | 1.63e-02 | 1.00e+00 | 5.931 | 1 | 2 | 16 |
GO:0006281 | DNA repair | 1.73e-02 | 1.00e+00 | 3.266 | 2 | 24 | 203 |
GO:0003899 | DNA-directed RNA polymerase activity | 1.83e-02 | 1.00e+00 | 5.762 | 1 | 3 | 18 |
GO:0036464 | cytoplasmic ribonucleoprotein granule | 1.93e-02 | 1.00e+00 | 5.684 | 1 | 1 | 19 |
GO:0005634 | nucleus | 1.93e-02 | 1.00e+00 | 1.074 | 7 | 158 | 3246 |
GO:0046966 | thyroid hormone receptor binding | 2.03e-02 | 1.00e+00 | 5.610 | 1 | 3 | 20 |
GO:0006370 | 7-methylguanosine mRNA capping | 2.43e-02 | 1.00e+00 | 5.347 | 1 | 5 | 24 |
GO:0001104 | RNA polymerase II transcription cofactor activity | 2.43e-02 | 1.00e+00 | 5.347 | 1 | 4 | 24 |
GO:0030901 | midbrain development | 2.53e-02 | 1.00e+00 | 5.288 | 1 | 1 | 25 |
GO:0016592 | mediator complex | 2.53e-02 | 1.00e+00 | 5.288 | 1 | 6 | 25 |
GO:0000976 | transcription regulatory region sequence-specific DNA binding | 2.53e-02 | 1.00e+00 | 5.288 | 1 | 3 | 25 |
GO:0051496 | positive regulation of stress fiber assembly | 2.63e-02 | 1.00e+00 | 5.231 | 1 | 2 | 26 |
GO:0006360 | transcription from RNA polymerase I promoter | 2.73e-02 | 1.00e+00 | 5.177 | 1 | 4 | 27 |
GO:0050885 | neuromuscular process controlling balance | 2.83e-02 | 1.00e+00 | 5.124 | 1 | 1 | 28 |
GO:0006418 | tRNA aminoacylation for protein translation | 2.93e-02 | 1.00e+00 | 5.073 | 1 | 4 | 29 |
GO:0006383 | transcription from RNA polymerase III promoter | 2.93e-02 | 1.00e+00 | 5.073 | 1 | 6 | 29 |
GO:0042752 | regulation of circadian rhythm | 2.93e-02 | 1.00e+00 | 5.073 | 1 | 5 | 29 |
GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity | 3.03e-02 | 1.00e+00 | 5.025 | 1 | 3 | 30 |
GO:0032154 | cleavage furrow | 3.03e-02 | 1.00e+00 | 5.025 | 1 | 3 | 30 |
GO:0005925 | focal adhesion | 3.21e-02 | 1.00e+00 | 2.792 | 2 | 14 | 282 |
GO:0021762 | substantia nigra development | 3.43e-02 | 1.00e+00 | 4.844 | 1 | 1 | 34 |
GO:0003712 | transcription cofactor activity | 3.43e-02 | 1.00e+00 | 4.844 | 1 | 3 | 34 |
GO:0050434 | positive regulation of viral transcription | 3.53e-02 | 1.00e+00 | 4.802 | 1 | 5 | 35 |
GO:0007266 | Rho protein signal transduction | 3.53e-02 | 1.00e+00 | 4.802 | 1 | 2 | 35 |
GO:0030521 | androgen receptor signaling pathway | 3.53e-02 | 1.00e+00 | 4.802 | 1 | 3 | 35 |
GO:0030900 | forebrain development | 3.63e-02 | 1.00e+00 | 4.762 | 1 | 2 | 36 |
GO:0030334 | regulation of cell migration | 3.63e-02 | 1.00e+00 | 4.762 | 1 | 2 | 36 |
GO:0048511 | rhythmic process | 3.83e-02 | 1.00e+00 | 4.684 | 1 | 5 | 38 |
GO:0006396 | RNA processing | 4.02e-02 | 1.00e+00 | 4.610 | 1 | 4 | 40 |
GO:0006283 | transcription-coupled nucleotide-excision repair | 4.02e-02 | 1.00e+00 | 4.610 | 1 | 6 | 40 |
GO:0004867 | serine-type endopeptidase inhibitor activity | 4.22e-02 | 1.00e+00 | 4.539 | 1 | 1 | 42 |
GO:0001047 | core promoter binding | 4.22e-02 | 1.00e+00 | 4.539 | 1 | 4 | 42 |
GO:0008203 | cholesterol metabolic process | 4.71e-02 | 1.00e+00 | 4.377 | 1 | 2 | 47 |
GO:0007626 | locomotory behavior | 4.71e-02 | 1.00e+00 | 4.377 | 1 | 1 | 47 |
GO:0032481 | positive regulation of type I interferon production | 4.81e-02 | 1.00e+00 | 4.347 | 1 | 3 | 48 |
GO:0006310 | DNA recombination | 5.01e-02 | 1.00e+00 | 4.288 | 1 | 8 | 50 |
GO:0006368 | transcription elongation from RNA polymerase II promoter | 5.20e-02 | 1.00e+00 | 4.231 | 1 | 8 | 52 |
GO:0006289 | nucleotide-excision repair | 5.30e-02 | 1.00e+00 | 4.204 | 1 | 6 | 53 |
GO:0045666 | positive regulation of neuron differentiation | 5.30e-02 | 1.00e+00 | 4.204 | 1 | 3 | 53 |
GO:0006936 | muscle contraction | 5.40e-02 | 1.00e+00 | 4.177 | 1 | 5 | 54 |
GO:0042826 | histone deacetylase binding | 5.79e-02 | 1.00e+00 | 4.073 | 1 | 5 | 58 |
GO:0000785 | chromatin | 5.88e-02 | 1.00e+00 | 4.049 | 1 | 6 | 59 |
GO:0071013 | catalytic step 2 spliceosome | 6.08e-02 | 1.00e+00 | 4.001 | 1 | 5 | 61 |
GO:0016032 | viral process | 6.83e-02 | 1.00e+00 | 2.190 | 2 | 30 | 428 |
GO:0010951 | negative regulation of endopeptidase activity | 7.04e-02 | 1.00e+00 | 3.782 | 1 | 2 | 71 |
GO:0030496 | midbody | 7.23e-02 | 1.00e+00 | 3.742 | 1 | 6 | 73 |
GO:0016363 | nuclear matrix | 7.23e-02 | 1.00e+00 | 3.742 | 1 | 10 | 73 |
GO:0005515 | protein binding | 7.32e-02 | 1.00e+00 | 0.729 | 7 | 198 | 4124 |
GO:0001649 | osteoblast differentiation | 7.33e-02 | 1.00e+00 | 3.722 | 1 | 5 | 74 |
GO:0051056 | regulation of small GTPase mediated signal transduction | 7.52e-02 | 1.00e+00 | 3.684 | 1 | 2 | 76 |
GO:0005938 | cell cortex | 7.61e-02 | 1.00e+00 | 3.665 | 1 | 6 | 77 |
GO:0005815 | microtubule organizing center | 7.61e-02 | 1.00e+00 | 3.665 | 1 | 4 | 77 |
GO:0030529 | ribonucleoprotein complex | 8.09e-02 | 1.00e+00 | 3.574 | 1 | 5 | 82 |
GO:0048015 | phosphatidylinositol-mediated signaling | 8.19e-02 | 1.00e+00 | 3.556 | 1 | 2 | 83 |
GO:0030027 | lamellipodium | 8.66e-02 | 1.00e+00 | 3.472 | 1 | 3 | 88 |
GO:0030036 | actin cytoskeleton organization | 8.85e-02 | 1.00e+00 | 3.440 | 1 | 4 | 90 |
GO:0006351 | transcription, DNA-templated | 8.87e-02 | 1.00e+00 | 1.445 | 3 | 47 | 1076 |
GO:0008201 | heparin binding | 8.94e-02 | 1.00e+00 | 3.424 | 1 | 4 | 91 |
GO:0007179 | transforming growth factor beta receptor signaling pathway | 1.04e-01 | 1.00e+00 | 3.190 | 1 | 5 | 107 |
GO:0043123 | positive regulation of I-kappaB kinase/NF-kappaB signaling | 1.05e-01 | 1.00e+00 | 3.177 | 1 | 2 | 108 |
GO:0006397 | mRNA processing | 1.07e-01 | 1.00e+00 | 3.150 | 1 | 12 | 110 |
GO:0004872 | receptor activity | 1.13e-01 | 1.00e+00 | 3.073 | 1 | 4 | 116 |
GO:0003924 | GTPase activity | 1.15e-01 | 1.00e+00 | 3.037 | 1 | 7 | 119 |
GO:0016020 | membrane | 1.16e-01 | 1.00e+00 | 1.279 | 3 | 56 | 1207 |
GO:0006184 | GTP catabolic process | 1.25e-01 | 1.00e+00 | 2.909 | 1 | 7 | 130 |
GO:0030168 | platelet activation | 1.35e-01 | 1.00e+00 | 2.792 | 1 | 5 | 141 |
GO:0044212 | transcription regulatory region DNA binding | 1.37e-01 | 1.00e+00 | 2.772 | 1 | 13 | 143 |
GO:0006355 | regulation of transcription, DNA-templated | 1.63e-01 | 1.00e+00 | 1.450 | 2 | 31 | 715 |
GO:0007264 | small GTPase mediated signal transduction | 1.65e-01 | 1.00e+00 | 2.489 | 1 | 8 | 174 |
GO:0000166 | nucleotide binding | 1.66e-01 | 1.00e+00 | 2.472 | 1 | 13 | 176 |
GO:0003779 | actin binding | 1.69e-01 | 1.00e+00 | 2.448 | 1 | 3 | 179 |
GO:0003713 | transcription coactivator activity | 1.73e-01 | 1.00e+00 | 2.408 | 1 | 21 | 184 |
GO:0005575 | cellular_component | 1.76e-01 | 1.00e+00 | 2.385 | 1 | 4 | 187 |
GO:0005856 | cytoskeleton | 1.78e-01 | 1.00e+00 | 2.362 | 1 | 8 | 190 |
GO:0005525 | GTP binding | 1.84e-01 | 1.00e+00 | 2.309 | 1 | 12 | 197 |
GO:0048011 | neurotrophin TRK receptor signaling pathway | 1.86e-01 | 1.00e+00 | 2.295 | 1 | 8 | 199 |
GO:0044822 | poly(A) RNA binding | 1.95e-01 | 1.00e+00 | 1.289 | 2 | 45 | 799 |
GO:0007275 | multicellular organismal development | 1.99e-01 | 1.00e+00 | 2.190 | 1 | 9 | 214 |
GO:0030054 | cell junction | 2.02e-01 | 1.00e+00 | 2.163 | 1 | 5 | 218 |
GO:0030198 | extracellular matrix organization | 2.05e-01 | 1.00e+00 | 2.144 | 1 | 7 | 221 |
GO:0007186 | G-protein coupled receptor signaling pathway | 2.11e-01 | 1.00e+00 | 2.092 | 1 | 4 | 229 |
GO:0007411 | axon guidance | 2.18e-01 | 1.00e+00 | 2.043 | 1 | 8 | 237 |
GO:0003723 | RNA binding | 2.26e-01 | 1.00e+00 | 1.983 | 1 | 22 | 247 |
GO:0005524 | ATP binding | 2.31e-01 | 1.00e+00 | 1.131 | 2 | 37 | 892 |
GO:0008150 | biological_process | 2.45e-01 | 1.00e+00 | 1.855 | 1 | 3 | 270 |
GO:0009986 | cell surface | 2.61e-01 | 1.00e+00 | 1.747 | 1 | 5 | 291 |
GO:0003674 | molecular_function | 2.66e-01 | 1.00e+00 | 1.717 | 1 | 4 | 297 |
GO:0005737 | cytoplasm | 2.72e-01 | 1.00e+00 | 0.569 | 4 | 127 | 2633 |
GO:0005829 | cytosol | 2.72e-01 | 1.00e+00 | 0.713 | 3 | 88 | 1787 |
GO:0045892 | negative regulation of transcription, DNA-templated | 2.81e-01 | 1.00e+00 | 1.623 | 1 | 17 | 317 |
GO:0007596 | blood coagulation | 2.98e-01 | 1.00e+00 | 1.526 | 1 | 13 | 339 |
GO:0006366 | transcription from RNA polymerase II promoter | 2.99e-01 | 1.00e+00 | 1.518 | 1 | 23 | 341 |
GO:0042802 | identical protein binding | 3.09e-01 | 1.00e+00 | 1.464 | 1 | 15 | 354 |
GO:0045893 | positive regulation of transcription, DNA-templated | 3.26e-01 | 1.00e+00 | 1.373 | 1 | 21 | 377 |
GO:0045087 | innate immune response | 3.78e-01 | 1.00e+00 | 1.111 | 1 | 12 | 452 |
GO:0000122 | negative regulation of transcription from RNA polymerase II promoter | 3.80e-01 | 1.00e+00 | 1.099 | 1 | 29 | 456 |
GO:0045944 | positive regulation of transcription from RNA polymerase II promoter | 4.95e-01 | 1.00e+00 | 0.601 | 1 | 29 | 644 |
GO:0005739 | mitochondrion | 5.03e-01 | 1.00e+00 | 0.567 | 1 | 32 | 659 |
GO:0070062 | extracellular vesicular exosome | 5.20e-01 | 1.00e+00 | 0.251 | 2 | 51 | 1641 |
GO:0005886 | plasma membrane | 5.70e-01 | 1.00e+00 | 0.131 | 2 | 46 | 1784 |
GO:0005730 | nucleolus | 7.36e-01 | 1.00e+00 | -0.318 | 1 | 74 | 1217 |
GO:0016021 | integral component of membrane | 8.17e-01 | 1.00e+00 | -0.644 | 1 | 19 | 1526 |